Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Influenza

Free Subscription 05.12.2022 1 BMC Pediatr 5 BMJ 1 Drug Saf 9 Epidemiol Infect 2 J Immunol 13 J Infect Dis 1 J Virol 1 J Virol Methods 1 JAMA 1 N Engl J Med 1 Pediatr Rev 2 Pediatrics 1 PLoS Biol 28 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Pediatr

1. MOKHTARINIA HR, Torkamani MH, Farmani O, Biglarian A, et al
   Smartphone addiction in children: patterns of use and musculoskeletal discomfort during the COVID-19 pandemic in Iran.
   BMC Pediatr. 2022;22:681.
   PubMed         Abstract available
   
   

   
   BMJ

2. CASTELLI JM, Rearte A, Olszevicki S, Voto C, et al
   Effectiveness of mRNA-1273, BNT162b2, and BBIBP-CorV vaccines against infection and mortality in children in Argentina, during predominance of delta and omicron covid-19 variants: test negative, case-control study.
   BMJ. 2022;379:e073070.
   PubMed         Abstract available
   
   
3. DYER O
   Covid-19: Protests against lockdowns in China reignite amid crackdown.
   BMJ. 2022;379:o2896.
   PubMed        
   
   
4. TORJESEN I
   Complaints against GPs up by more than a third on pre-covid level.
   BMJ. 2022;379:o2891.
   PubMed        
   
   
5. ROE J, Brady G, Emery L, Walker S, et al
   Co-design of new post-covid oncology rehabilitation services offers a model for the future.
   BMJ. 2022;379:o2875.
   PubMed        
   
   
6. LOSEVA P
   Preoccupied with the war, Russia skipped one wave of covid and ignored another.
   BMJ. 2022;379:o2825.
   PubMed        
   
   

   
   Drug Saf

7. WAN EYF, Chui CSL, Mok AHY, Xu W, et al
   mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccination and Risk of Adverse Events and Acute Diabetic Complications in Patients with Type 2 Diabetes Mellitus: A Population-Based Study.
   Drug Saf. 2022;45:1477-1490.
   PubMed         Abstract available
   
   

   
   Epidemiol Infect

8. EBERHARDT AT, Simoncini M, Pina C, Galoppo G, et al
   Preceding anti-spike IgG levels predicted risk and severity of COVID-19 during the Omicron-dominant wave in Santa Fe city, Argentina.
   Epidemiol Infect. 2022;150:e187.
   PubMed         Abstract available
   
   
9. TSUZUKI S, Akiyama T, Matsunaga N, Ohmagari N, et al
   Association between physical activity status and severity of COVID-19 in older adults.
   Epidemiol Infect. 2022;150:e189.
   PubMed         Abstract available
   
   
10. VALLEE A
    Underestimation of the number of COVID-19 cases, an epidemiological threat.
    Epidemiol Infect. 2022;150:e191.
    PubMed        
    
    
11. LE GLASS E, Raoult D, Dubourg G
    Snapshot of COVID-19 superinfections in Marseille hospitals: where are the common pathogens?
    Epidemiol Infect. 2022;150:e195.
    PubMed         Abstract available
    
    
12. MIYAMA T, Jung SM, Nishiura H
    Decrease in overdispersed secondary transmission of COVID-19 over time in Japan.
    Epidemiol Infect. 2022;150:e197.
    PubMed         Abstract available
    
    
13. BHUIYAN MS, Brintz BJ, Whitcombe AL, Markmann AJ, et al
    Combining antibody markers for serosurveillance of SARS-CoV-2 to estimate seroprevalence and time-since-infection - CORRIGENDUM.
    Epidemiol Infect. 2022;150:e188.
    PubMed        
    
    
14. HEIJMINK L, Tonis J, Gilhuis N, Gerkema M, et al
    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.
    Epidemiol Infect. 2022;150:e193.
    PubMed         Abstract available
    
    
15. LEE YH, Choe YJ, Lee H, Choi EH, et al
    Spatial distribution of SARS-CoV-2 infection in schools, South Korea.
    Epidemiol Infect. 2022;150:e194.
    PubMed         Abstract available
    
    
16. PANDEY BD, Ngwe Tun MM, Pandey K, Dumre SP, et al
    Has COVID-19 suppressed dengue transmission in Nepal?
    Epidemiol Infect. 2022;150:e196.
    PubMed         Abstract available
    
    

    
    J Immunol

17. BREZNIK JA, Huynh A, Zhang A, Bilaver L, et al
    Cytomegalovirus Seropositivity in Older Adults Changes the T Cell Repertoire but Does Not Prevent Antibody or Cellular Responses to SARS-CoV-2 Vaccination.
    J Immunol. 2022;209:1892-1905.
    PubMed         Abstract available
    
    
18. MISE-OMATA S, Ikeda M, Takeshita M, Uwamino Y, et al
    Memory B Cells and Memory T Cells Induced by SARS-CoV-2 Booster Vaccination or Infection Show Different Dynamics and Responsiveness to the Omicron Variant.
    J Immunol. 2022;209:2104-2113.
    PubMed         Abstract available
    
    

    
    J Infect Dis

19. AMANO M, Maeda K, Tsuchiya K, Shimada S, et al
    Third-dose BNT162b2 vaccination elicits markedly high-level SARS-CoV-2-neutralizing antibodies in vaccinees who poorly responded to second dose in Japan.
    J Infect Dis. 2022 May 17. pii: 6587098. doi: 10.1093.
    PubMed        
    
    
20. SIEDNER MJ, Alba C, Fitzmaurice KP, Gilbert RF, et al
    Cost-effectiveness of COVID-19 vaccination in low- and middle-income countries.
    J Infect Dis. 2022 Jun 13. pii: 6606162. doi: 10.1093.
    PubMed         Abstract available
    
    
21. AMJADI MF, Adyniec RR, Gupta S, Bashar SJ, et al
    Anti-membrane antibodies persist at least one year and discriminate between past COVID-19 infection and vaccination.
    J Infect Dis. 2022 Jun 27. pii: 6618636. doi: 10.1093.
    PubMed         Abstract available
    
    
22. PADHI S, Nayak N, Sarangi S, Nahak SK, et al
    Association of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Related Mortality Rates With Mental Disorders: An Epidemiological Correlation in the Indian Population.
    J Infect Dis. 2022;226:2037-2038.
    PubMed        
    
    
23. LIU B, Stepien S, Pye V, Law C, et al
    High attack rate of SARS-CoV-2 B.1.1.529 among two-dose vaccinated populations in two indoor entertainment setting outbreaks.
    J Infect Dis. 2022 May 7. pii: 6582820. doi: 10.1093.
    PubMed         Abstract available
    
    
24. LIN DY, Zeng D, Gu Y, Krause PR, et al
    Reliably Assessing Duration of Protection for COVID-19 Vaccines.
    J Infect Dis. 2022 Apr 21. pii: 6571630. doi: 10.1093.
    PubMed         Abstract available
    
    
25. STIRRUP O, Krutikov M, Tut G, Palmer T, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Antibody Levels Following Second Dose of ChAdOx1 nCov-19 or BNT162b2 Vaccine in Residents of Long-term Care Facilities in England (VIVALDI).
    J Infect Dis. 2022;226:1877-1881.
    PubMed         Abstract available
    
    
26. VIVALDI G, Jolliffe DA, Faustini S, Shields AM, et al
    Correlation between post-vaccination anti-Spike antibody titres and protection against breakthrough SARS-CoV-2 infection: a population-based longitudinal study.
    J Infect Dis. 2022 Jul 30. pii: 6652292. doi: 10.1093.
    PubMed         Abstract available
    
    
27. ROSSLER A, Kimpel J, Fleischer V, Huber S, et al
    Regimen of COVID-19 vaccination influences extent and kinetics of antibody avidity.
    J Infect Dis. 2022 Sep 16. pii: 6701886. doi: 10.1093.
    PubMed         Abstract available
    
    
28. FURUKAWA K, Kurahashi Y, Ishimaru H, Nishimura M, et al
    The number of COVID-19 vaccine doses and severe clinical outcomes in older patients infected with a SARS-CoV-2 Omicron variant.
    J Infect Dis. 2022 Sep 26. pii: 6717967. doi: 10.1093.
    PubMed        
    
    
29. BENET S, Blanch-Lombarte O, Ainsua-Enrich E, Pedreno-Lopez N, et al
    Limited humoral and specific T-cell responses after SARS-CoV-2 vaccination in PLWH with poor immune reconstitution.
    J Infect Dis. 2022 Oct 6. pii: 6749018. doi: 10.1093.
    PubMed         Abstract available
    
    
30. LAAKE I, Skodvin SN, Blix K, Caspersen IH, et al
    Effectiveness of mRNA booster vaccination against mild, moderate, and severe COVID-19 caused by the Omicron variant in a large, population-based, Norwegian cohort.
    J Infect Dis. 2022 Oct 19. pii: 6763324. doi: 10.1093.
    PubMed         Abstract available
    
    
31. ANDERSON M, Stec M, Gosha A, Mohammad T, et al
    Longitudinal SARS-CoV-2 Vaccine Antibody Responses and Identification of Vaccine Breakthrough Infections Among Healthcare Workers Using Nucleocapsid IgG.
    J Infect Dis. 2022 Oct 20. pii: 6764413. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Virol

32. BELSER JA, Sun X, Kieran TJ, Brock N, et al
    Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    J Virol. 2022 Nov 30:e0140322. doi: 10.1128/jvi.01403.
    PubMed         Abstract available
    
    

    
    J Virol Methods

33. MCMINN BR, Korajkic A, Pemberton AC, Kelleher J, et al
    Assessment of two volumetrically different concentration approaches to improve sensitivities for SARS-CoV-2 detection during wastewater monitoring.
    J Virol Methods. 2023;311:114645.
    PubMed         Abstract available
    
    

    
    JAMA

34. KUEHN BM
    Targeted Flu Vaccination Campaigns Needed for Certain Racial and Ethnic Groups.
    JAMA. 2022;328:2005.
    PubMed        
    
    

    
    N Engl J Med

35. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Five Disease Outbreaks beyond Covid-19.
    N Engl J Med. 2022;387:e68.
    PubMed        
    
    

    
    Pediatr Rev

36. EGGE JA, Anderson RH, Schimelpfenig MD
    Care of the Well Newborn.
    Pediatr Rev. 2022;43:676-690.
    PubMed         Abstract available
    
    

    
    Pediatrics

37. BREWER AG, Doss W, Sheehan KM, Davis MM, et al
    Trends in Suicidal Ideation-Related Emergency Department Visits for Youth in Illinois: 2016-2021.
    Pediatrics. 2022;150:e2022056793.
    PubMed         Abstract available
    
    
38. ARONSON PL, Kerns E, Jennings B, Magee S, et al
    Trends in Prevalence of Bacterial Infections in Febrile Infants During the COVID-19 Pandemic.
    Pediatrics. 2022 Nov 10. pii: 189929. doi: 10.1542/peds.2022-059235.
    PubMed         Abstract available
    
    

    
    PLoS Biol

39. NIEMEYER D, Stenzel S, Veith T, Schroeder S, et al
    SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.
    PLoS Biol. 2022;20:e3001871.
    PubMed         Abstract available
    
    

    
    PLoS One

40. SCHMIDT V, Kaiser J, Treml J, Kersting A, et al
    Factors associated with pre-loss grief and preparedness in relatives of people with cancer during the COVID-19 pandemic: A cross-sectional study.
    PLoS One. 2022;17:e0278271.
    PubMed         Abstract available
    
    
41. HAKIM A, Salman ANM, Ashari Y, Syuhada K, et al
    Modifying (M)CoVaR and constructing tail risk networks through analytic higher-order moments: Evidence from the global forex markets.
    PLoS One. 2022;17:e0277756.
    PubMed         Abstract available
    
    
42. BLUKACZ A, Cabieses B, Obach A, Madrid P, et al
    "If I get sick here, I will never see my children again": The mental health of international migrants during the COVID-19 pandemic in Chile.
    PLoS One. 2022;17:e0277517.
    PubMed         Abstract available
    
    
43. FERNANDES AT, Rodrigues EK, Araujo ER, Formiga MF, et al
    Risk factors and survival in patients with COVID-19 in northeastern Brazil.
    PLoS One. 2022;17:e0278213.
    PubMed         Abstract available
    
    
44. ALEMU A, Bitew ZW, Seid G, Diriba G, et al
    Tuberculosis in individuals who recovered from COVID-19: A systematic review of case reports.
    PLoS One. 2022;17:e0277807.
    PubMed         Abstract available
    
    
45. YUAN L, Wang M
    The emotion bias of health product consumers in the context of COVID-19.
    PLoS One. 2022;17:e0278219.
    PubMed         Abstract available
    
    
46. CARVACHE-FRANCO O, Loaiza-Torres J, Soto-Montenegro C, Carvache-Franco M, et al
    The risks perceived by the consumer in the acceptance of electronic commerce. A study of Bolivia.
    PLoS One. 2022;17:e0276853.
    PubMed         Abstract available
    
    
47. CAMBIER M, Henket M, Frix AN, Gofflot S, et al
    Increased KL-6 levels in moderate to severe COVID-19 infection.
    PLoS One. 2022;17:e0273107.
    PubMed         Abstract available
    
    
48. HAJDU N, Schmidt K, Acs G, Roer JP, et al
    Contextual factors predicting compliance behavior during the COVID-19 pandemic: A machine learning analysis on survey data from 16 countries.
    PLoS One. 2022;17:e0276970.
    PubMed         Abstract available
    
    
49. GINIGE S, Firman E, Li YS, Soonarane Y, et al
    Protocol for a winter sentinel surveillance program of notifiable respiratory viruses in Queensland.
    PLoS One. 2022;17:e0277895.
    PubMed         Abstract available
    
    
50. KAMJAI P, Hemvimol S, Bordeerat NK, Srimanote P, et al
    Evaluation of emerging inflammatory markers for predicting oxygen support requirement in COVID-19 patients.
    PLoS One. 2022;17:e0278145.
    PubMed         Abstract available
    
    
51. M A KAWSAR S, Hosen MA, Ahmad S, El Bakri Y, et al
    Potential SARS-CoV-2 RdRp inhibitors of cytidine derivatives: Molecular docking, molecular dynamic simulations, ADMET, and POM analyses for the identification of pharmacophore sites.
    PLoS One. 2022;17:e0273256.
    PubMed         Abstract available
    
    
52. ABOULATTA L, Peymani P, Vaccaro C, Leong C, et al
    Drug utilization patterns before and during COVID-19 pandemic in Manitoba, Canada: A population-based study.
    PLoS One. 2022;17:e0278072.
    PubMed         Abstract available
    
    
53. LANG M, Allard A, Blomqvist S, Iranto I, et al
    Multicenter evaluation of the GenomEra SARS-CoV-2 assay kit.
    PLoS One. 2022;17:e0277925.
    PubMed         Abstract available
    
    
54. VERDE P, Marcantonio C, Costantino A, Martina A, et al
    Diagnostic accuracy of a SARS-CoV-2 rapid antigen test among military and civilian personnel of an Air Force airport in central Italy.
    PLoS One. 2022;17:e0277904.
    PubMed         Abstract available
    
    
55. HSIAO K, Zegzouti H, Goueli S
    High throughput bioluminescent assay to characterize and monitor the activity of SARS-CoV-2 methyltransferases.
    PLoS One. 2022;17:e0274343.
    PubMed         Abstract available
    
    
56. ROGERS A, Brazier E, Dzudie A, Adedimeji A, et al
    COVID-19 associated changes in HIV service delivery over time in Central Africa: Results from facility surveys during the first and second waves of the pandemic.
    PLoS One. 2022;17:e0275429.
    PubMed         Abstract available
    
    
57. SAKYI B, Amoako Johnson F
    A cross-sectional study of the psychological impact of the COVID-19 pandemic on camped refugees in Ghana.
    PLoS One. 2022;17:e0277515.
    PubMed         Abstract available
    
    
58. VAN DER FELTZ-CORNELIS CM, Sweetman J, Allsopp G, Attree E, et al
    STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study protocol.
    PLoS One. 2022;17:e0277936.
    PubMed         Abstract available
    
    
59. BRAILOVSKAIA J, Margraf J
    Positive mental health and mindfulness as protective factors against addictive social media use during the COVID-19 outbreak.
    PLoS One. 2022;17:e0277631.
    PubMed         Abstract available
    
    
60. RAI SN, Das S, Pan J, Mishra DC, et al
    Multigroup prediction in lung cancer patients and comparative controls using signature of volatile organic compounds in breath samples.
    PLoS One. 2022;17:e0277431.
    PubMed         Abstract available
    
    
61. VAN DEN BERG LMM, Akooji N, Thomson G, de Jonge A, et al
    Making maternity and neonatal care personalised in the COVID-19 pandemic: Results from the Babies Born Better survey in the UK and the Netherlands.
    PLoS One. 2022;17:e0267415.
    PubMed         Abstract available
    
    
62. SIMKOVICH SM, Ahmed N, Chou J, McCullers A, et al
    Health, social, and economic characteristics of patients enrolled in a COVID-19 recovery program.
    PLoS One. 2022;17:e0278154.
    PubMed         Abstract available
    
    
63. VOLTA M, Giostra U, Guariso G, Baldasano J, et al
    The greatest air quality experiment ever: Policy suggestions from the COVID-19 lockdown in twelve European cities.
    PLoS One. 2022;17:e0277428.
    PubMed         Abstract available
    
    
64. BIESBROEK G, Kapitein B, Kuipers IM, Gruppen MP, et al
    Inflammatory responses in SARS-CoV-2 associated Multisystem Inflammatory Syndrome and Kawasaki Disease in children: An observational study.
    PLoS One. 2022;17:e0266336.
    PubMed         Abstract available
    
    
65. OMER AAM, Hinkula J, Tran PT, Melik W, et al
    Plantaricin NC8 alphabeta rapidly and efficiently inhibits flaviviruses and SARS-CoV-2 by disrupting their envelopes.
    PLoS One. 2022;17:e0278419.
    PubMed         Abstract available
    
    
66. NAZ S, Dur E Shawar S, Saleem S, Malik A, et al
    Knowledge, attitudes, and practices (KAP) towards COVID-19 pandemic among pregnant women in a tertiary hospital in Karachi, Pakistan.
    PLoS One. 2022;17:e0274252.
    PubMed         Abstract available
    
    
67. OTIENO G, Rawlings NN
    Impact of non-pharmaceutical interventions targeted at the COVID-19 pandemic on the incidence of influenza-like illness in the UK Armed Forces.
    PLoS One. 2022;17:e0270438.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

68. SMERDON D
    The effect of masks on cognitive performance.
    Proc Natl Acad Sci U S A. 2022;119:e2206528119.
    PubMed         Abstract available
    
    
69. BAKER RE, Saad-Roy CM, Park SW, Farrar J, et al
    Long-term benefits of nonpharmaceutical interventions for endemic infections are shaped by respiratory pathogen dynamics.
    Proc Natl Acad Sci U S A. 2022;119:e2208895119.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: